| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.7M | +3.2% | +15.3% |
| R&D Expense | $849K | — | +17.6% |
| Operating Income | $2.6M | -32.8% | +29.7% |
| Pre-tax Income | $2.9M | -30.0% | +35.2% |
| Income Tax | $470K | -28.5% | -2.9% |
| Net Income | $2.4M | -30.3% | +46.5% |
| EPS (Basic) | $0.68 | -41.4% | +19.3% |
| EPS (Diluted) | $0.67 | -32.3% | +19.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $52.0M | +148.7% | +280.3% |
| Accounts Receivable | $8.1M | +21.3% | +20.2% |
| Inventory | $10.3M | +7.0% | +10.5% |
| Current Assets | $71.9M | +17.5% | +136.3% |
| Total Assets | $79.3M | +16.0% | +110.0% |
| Current Liabilities | $6.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.1M | — | +31.8% |
| Capital Expenditures | $452K | — | -22.9% |
| Investing Cash Flow | -$452K | — | +22.9% |
| Financing Cash Flow | $29.4M | — | — |
| Free Cash Flow | $1.7M | — | +63.2% |
| +33.7% |
| Total Liabilities | $6.2M | +20.8% | +35.3% |
| Stockholders' Equity | $73.1M | +15.6% | +120.4% |